caffeine has been researched along with Obesity, Morbid in 8 studies
Obesity, Morbid: The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Bariatric surgery resulted in faster absorption and normalized pharmacokinetic parameters, prompting an increase in paracetamol bioavailability." | 6.84 | Pharmacokinetics in Morbid Obesity: Influence of Two Bariatric Surgery Techniques on Paracetamol and Caffeine Metabolism. ( Boix, DB; Civit, E; de la Torre, R; Farré, M; Goday Arno, A; Grande, L; Langohr, K; Le Roux, JAF; Lí Carbó, M; Nino, OC; Papaseit, E; Pera, M; Pérez-Mañá, C; Ramon, JM; Rodríguez-Morató, J, 2017) |
| " Body weight, plasma levels of adrenaline, noradrenaline, triglycerides, free fatty acids, glycerol, TSH, fT4, and fT3 were assessed, as well as fasting glucose, insulin and HOMA index, at baseline and at the end of treatments." | 5.19 | Muscle uncoupling protein 3 expression is unchanged by chronic ephedrine/caffeine treatment: results of a double blind, randomised clinical trial in morbidly obese females. ( Bracale, R; Bracale, U; Carruba, MO; Davinelli, S; Nisoli, E; Petroni, ML; Scapagnini, G, 2014) |
| " Bariatric surgery resulted in faster absorption and normalized pharmacokinetic parameters, prompting an increase in paracetamol bioavailability." | 2.84 | Pharmacokinetics in Morbid Obesity: Influence of Two Bariatric Surgery Techniques on Paracetamol and Caffeine Metabolism. ( Boix, DB; Civit, E; de la Torre, R; Farré, M; Goday Arno, A; Grande, L; Langohr, K; Le Roux, JAF; Lí Carbó, M; Nino, OC; Papaseit, E; Pera, M; Pérez-Mañá, C; Ramon, JM; Rodríguez-Morató, J, 2017) |
| " Incorporation of the relevant physiological and biochemical changes into predictive bottom-up pharmacokinetic models in order to optimize dosage regimens may offer a logical way forward for the cases where no clinical data exist." | 1.37 | Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance. ( Aarabi, M; Allabi, AC; Almond, LM; Ghobadi, C; Jamei, M; Johnson, TN; Rostami-Hodjegan, A; Rowland-Yeo, K, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goday Arno, A | 1 |
| Farré, M | 2 |
| Rodríguez-Morató, J | 2 |
| Ramon, JM | 1 |
| Pérez-Mañá, C | 2 |
| Papaseit, E | 1 |
| Civit, E | 1 |
| Langohr, K | 2 |
| Lí Carbó, M | 1 |
| Boix, DB | 1 |
| Nino, OC | 1 |
| Le Roux, JAF | 1 |
| Pera, M | 1 |
| Grande, L | 1 |
| de la Torre, R | 2 |
| Goday, A | 1 |
| Ferreira, V | 1 |
| Wang, JJ | 1 |
| Villeneuve, E | 1 |
| Gosselin, S | 1 |
| Bracale, R | 1 |
| Petroni, ML | 2 |
| Davinelli, S | 1 |
| Bracale, U | 1 |
| Scapagnini, G | 1 |
| Carruba, MO | 1 |
| Nisoli, E | 1 |
| Wegrzyn, NM | 1 |
| Ghobadi, C | 1 |
| Johnson, TN | 1 |
| Aarabi, M | 1 |
| Almond, LM | 1 |
| Allabi, AC | 1 |
| Rowland-Yeo, K | 1 |
| Jamei, M | 1 |
| Rostami-Hodjegan, A | 1 |
| Anty, R | 1 |
| Marjoux, S | 1 |
| Iannelli, A | 1 |
| Patouraux, S | 1 |
| Schneck, AS | 1 |
| Bonnafous, S | 1 |
| Gire, C | 1 |
| Amzolini, A | 1 |
| Ben-Amor, I | 1 |
| Saint-Paul, MC | 1 |
| Mariné-Barjoan, E | 1 |
| Pariente, A | 1 |
| Gugenheim, J | 1 |
| Gual, P | 1 |
| Tran, A | 1 |
| De Matteis, R | 1 |
| Arch, JR | 1 |
| Ferrari, D | 1 |
| Cinti, S | 1 |
| Stock, MJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pharmacokinetics in Morbid Obesity: Influence of Two Bariatric Surgery Techniques in Drugs Metabolism.[NCT01086722] | Phase 1/Phase 2 | 52 participants (Actual) | Interventional | 2010-02-28 | Completed | ||
| Evaluation of Diet and Treatment With a Combination of Ephedrine and Caffeine on Thermogenesis, Cardiac Function and on Uncoupling Proteins Expression in Adipose and Muscle Tissue of Morbid Obese Patients Undergoing Bariatric Surgery.[NCT02048215] | Phase 3 | 13 participants (Actual) | Interventional | 2000-02-29 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for caffeine and Obesity, Morbid
| Article | Year |
|---|---|
Pharmacokinetics in Morbid Obesity: Influence of Two Bariatric Surgery Techniques on Paracetamol and Caffeine Metabolism.
Topics: Acetaminophen; Adolescent; Adult; Bariatric Surgery; Biomarkers; Caffeine; Female; Gastrectomy; Gast | 2017 |
Muscle uncoupling protein 3 expression is unchanged by chronic ephedrine/caffeine treatment: results of a double blind, randomised clinical trial in morbidly obese females.
Topics: Administration, Oral; Adult; Basal Metabolism; Body Weight; Caffeine; Ephedrine; Epinephrine; Fatty | 2014 |
Immunohistochemical identification of the beta(3)-adrenoceptor in intact human adipocytes and ventricular myocardium: effect of obesity and treatment with ephedrine and caffeine.
Topics: Adipocytes; Adipose Tissue; Adolescent; Adrenergic beta-Agonists; Adult; Caffeine; Ephedrine; Female | 2002 |
5 other studies available for caffeine and Obesity, Morbid
| Article | Year |
|---|---|
Answer to the Letter to the Editor Concerning "Pharmacokinetics in Morbid Obesity: Influence of Two Bariatric Surgery Techniques on Paracetamol and Caffeine Metabolism".
Topics: Acetaminophen; Bariatric Surgery; Caffeine; Gastric Bypass; Humans; Obesity, Morbid | 2017 |
Letter in Reply to Arno et al. "Pharmacokinetics in Morbid Obesity: Influence of Two Bariatric Surgery Techniques on Paracetamol and Caffeine Metabolism".
Topics: Acetaminophen; Bariatric Surgery; Caffeine; Gastric Bypass; Humans; Obesity, Morbid | 2017 |
Malabsorption of L-T4 Due to Drip Coffee: A Case Report Using Predictors of Causation.
Topics: Caffeine; Coffee; Diabetes Mellitus, Type 2; Drug Interactions; Fasting; Female; Hashimoto Disease; | 2016 |
Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance.
Topics: Adolescent; Adult; Aged; Benzodiazepines; Body Weights and Measures; Caffeine; Chlorzoxazone; Comput | 2011 |
Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery.
Topics: Adult; Bariatric Surgery; Biopsy; Cacao; Caffeine; Coffee; Cohort Studies; Cola; Comorbidity; Europe | 2012 |